MX348595B - Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. - Google Patents

Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.

Info

Publication number
MX348595B
MX348595B MX2013008992A MX2013008992A MX348595B MX 348595 B MX348595 B MX 348595B MX 2013008992 A MX2013008992 A MX 2013008992A MX 2013008992 A MX2013008992 A MX 2013008992A MX 348595 B MX348595 B MX 348595B
Authority
MX
Mexico
Prior art keywords
release
production process
pharmaceutical composition
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
MX2013008992A
Other languages
English (en)
Other versions
MX2013008992A (es
Inventor
Amezcua Amezcua Federico
Covarrubias Pinedo Amador
Original Assignee
Laboratorio Raam De Sahuayo S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Raam De Sahuayo S A De C V filed Critical Laboratorio Raam De Sahuayo S A De C V
Priority to MX2013008992A priority Critical patent/MX348595B/es
Publication of MX2013008992A publication Critical patent/MX2013008992A/es
Priority to PCT/MX2014/000117 priority patent/WO2015016698A1/es
Priority to EP14831491.7A priority patent/EP3028706B1/en
Priority to ES14831491T priority patent/ES2832300T3/es
Priority to CA2946158A priority patent/CA2946158C/en
Priority to US14/909,509 priority patent/US20160243040A1/en
Publication of MX348595B publication Critical patent/MX348595B/es
Priority to CY20201101091T priority patent/CY1123695T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención presentacomposiciones farmacéuticas caracterizadas porque comprenden un sistema trifásico de liberación ya sea liberación retardada y/o liberación prolongada y/o liberación modificada y/o liberacipon inmediata, de al menos tres capas para la formación de al menos una unidad de dosificación, donde cada capa comprende como ingredientes farmacéuticos activos, al menos un agente corticosteroide del tipo betametasona y/o sus sales farmacéuticamente aceptables, al menos un agente antiinflamatorio no esteroideo del tipo aceclofenaco y/o sus sales farmacéuticamente aceptables, al menos un excipiente farmacéuticamente aceptable. Asimismo describe el novedoso proceso de producción. Dicho sistema trifásico de liberación ejerce un mejor efecto de tratamiento contra la desinflamación y el dolor corporal.
MX2013008992A 2013-08-02 2013-08-02 Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. MX348595B (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2013008992A MX348595B (es) 2013-08-02 2013-08-02 Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
PCT/MX2014/000117 WO2015016698A1 (es) 2013-08-02 2014-07-24 Composición farmacéutica con agentes antiinflamatorios y proceso de producción
EP14831491.7A EP3028706B1 (en) 2013-08-02 2014-07-24 Pharmaceutical composition with antiinflammatory agents and production process
ES14831491T ES2832300T3 (es) 2013-08-02 2014-07-24 Composición farmacéutica con agentes antiinflamatorios y proceso de producción
CA2946158A CA2946158C (en) 2013-08-02 2014-07-24 Pharmaceutical composition with anti-inflammatory agents and production process
US14/909,509 US20160243040A1 (en) 2013-08-02 2014-07-24 Pharmaceutical Composition with Antiinflammatory Agents and Production Process
CY20201101091T CY1123695T1 (el) 2013-08-02 2020-11-17 Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013008992A MX348595B (es) 2013-08-02 2013-08-02 Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.

Publications (2)

Publication Number Publication Date
MX2013008992A MX2013008992A (es) 2014-03-27
MX348595B true MX348595B (es) 2017-06-21

Family

ID=50935217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008992A MX348595B (es) 2013-08-02 2013-08-02 Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.

Country Status (7)

Country Link
US (1) US20160243040A1 (es)
EP (1) EP3028706B1 (es)
CA (1) CA2946158C (es)
CY (1) CY1123695T1 (es)
ES (1) ES2832300T3 (es)
MX (1) MX348595B (es)
WO (1) WO2015016698A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12290526B2 (en) 2018-08-13 2025-05-06 Federico Amezcua Amezcua Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses
MX2018013893A (es) * 2018-11-12 2019-05-13 Productos Maver S A De C V Composicion topica estable.
MX2019000312A (es) * 2019-01-08 2019-10-09 Federico Amezcua Amezcua Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874586A (en) * 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
KR20030041577A (ko) 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
US8940755B2 (en) 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
LT2522365T (lt) 2004-11-24 2017-02-10 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
WO2007072503A2 (en) 2005-12-21 2007-06-28 Panacea Biotec Ltd. Combinations for managing inflammation and associated disorders
KR101050076B1 (ko) * 2009-02-04 2011-07-19 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
US20120064159A1 (en) * 2009-05-28 2012-03-15 Aptapharma, Inc. Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
KR101234254B1 (ko) * 2010-06-01 2013-02-18 한국유나이티드제약 주식회사 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제

Also Published As

Publication number Publication date
US20160243040A1 (en) 2016-08-25
CA2946158A1 (en) 2015-02-05
EP3028706A1 (en) 2016-06-08
ES2832300T3 (es) 2021-06-10
EP3028706A4 (en) 2017-04-26
EP3028706B1 (en) 2020-08-19
MX2013008992A (es) 2014-03-27
CY1123695T1 (el) 2022-03-24
WO2015016698A1 (es) 2015-02-05
CA2946158C (en) 2022-01-18

Similar Documents

Publication Publication Date Title
PH12018501807A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseas
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
BR112015018087A8 (pt) composto, composição farmacêutica e uso
JP2012193216A5 (es)
EA201690223A1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
WO2015097621A3 (en) Pharmaceutical combinations
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
BR112018012870A2 (pt) métodos e composições para o tratamento de transtornos relacionados à crise
WO2013022243A3 (ko) 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
HK1231390A1 (zh) 用於局部给药的药用组合物
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
HK1222539A1 (zh) Pim激酶抑制剂组合
CY1123695T1 (el) Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης
MX363389B (es) Composicion farmaceutica que comprende ivabradina amorfa.
HK1215672A1 (zh) 用於治療炎症和癌症的吲哚類化合物
WO2014145126A3 (en) Methods of treating dyskinesia and related disorders
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
WO2014007549A3 (ko) 에스-알릴-엘-시스테인을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물 및 이를 포함하는 의약제제
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
WO2020036478A3 (es) Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor en las formas localizadas de afecciones reumáticas

Legal Events

Date Code Title Description
FG Grant or registration